TIM-1 Rabbit Polyclonal Antibody
To Order Contact Us Below:
 Anti-TIM 3/HAVCR2 Antibody |
|
A00657-1 |
BosterBio |
100ug/vial |
EUR 352.8 |
 HRP-Goat Anti-Rabbit Secondary Antibody |
|
A12004 |
EpiGentek |
|
|
 TIM-1 Antibody |
|
3811-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma. |
TIM-1 Antibody |
|
3811-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma. |
TIM-1 Antibody |
|
3809-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma. |
TIM-1 Antibody |
|
3809-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma. |
TIM-1 Antibody |
|
24416-100ul |
SAB |
100ul |
EUR 468 |
TIM-1 Antibody |
|
24417-100ul |
SAB |
100ul |
EUR 468 |
 Goat Anti-Rabbit Secondary Antibody, Biotin Conjugated |
|
A12001 |
EpiGentek |
|
|
 Oncogene TIM Polyclonal Antibody |
|
ABP56598-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of Oncogene TIM from Human, Mouse, Rat. This Oncogene TIM antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Oncogene TIM at AA range: 160-240 |
Oncogene TIM Polyclonal Antibody |
|
ABP56598-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of Oncogene TIM from Human, Mouse, Rat. This Oncogene TIM antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Oncogene TIM at AA range: 160-240 |
Oncogene TIM Polyclonal Antibody |
|
ABP56598-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of Oncogene TIM from Human, Mouse, Rat. This Oncogene TIM antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Oncogene TIM at AA range: 160-240 |
 Polyclonal Tim-3 Antibody |
|
APR00202G |
Leading Biology |
0.1mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Tim-3 . This antibody is tested and proven to work in the following applications: |
 Polyclonal TIM-4 Antibody |
|
APR06408G |
Leading Biology |
0.1 mg |
EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIM-4 . This antibody is tested and proven to work in the following applications: |
Polyclonal TIM-4 Antibody |
|
APR06409G |
Leading Biology |
0.1 mg |
EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIM-4 . This antibody is tested and proven to work in the following applications: |
Oncogene TIM Polyclonal Antibody |
|
ES7597-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Oncogene TIM from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Oncogene TIM Polyclonal Antibody |
|
ES7597-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Oncogene TIM from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
 Anti-TIM-1 antibody |
|
STJ98725 |
St John's Laboratory |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to TIM-1. |
 TIM antibody |
|
10R-10306 |
Fitzgerald |
100 ug |
EUR 522 |
|
Description: Mouse monoclonal TIM antibody |
TIM antibody |
|
10R-10307 |
Fitzgerald |
100 ug |
EUR 522 |
|
Description: Mouse monoclonal TIM antibody |
 TIM-1 Peptide |
|
43-672P |
ProSci |
0.1 mg |
EUR 405.6 |
TIM-1 Peptide |
|
3811P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (IN) TIM-1 peptide |
TIM-1 Peptide |
|
3809P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (NT) TIM-1 peptide |
 anti-TIM 1 |
|
YF-PA18329 |
Abfrontier |
50 ug |
EUR 435.6 |
|
Description: Mouse polyclonal to TIM 1 |
anti-TIM 1 |
|
YF-PA18330 |
Abfrontier |
100 ug |
EUR 483.6 |
|
Description: Rabbit polyclonal to TIM 1 |
anti-TIM 1 |
|
YF-PA26016 |
Abfrontier |
50 ul |
EUR 400.8 |
|
Description: Mouse polyclonal to TIM 1 |
) Polyclonal Goat Anti-TIM-1 Antibody (internal region) |
|
APR11107G |
Leading Biology |
0.1mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-TIM-1 (internal region). This antibody is tested and proven to work in the following applications: |
 Anti-TIM 1/HAVCR1 Antibody |
|
A01306 |
BosterBio |
100ug/vial |
EUR 352.8 |
Anti-TIM 1/HAVCR1 Antibody |
|
PA1624 |
BosterBio |
100ug/vial |
EUR 400.8 |
Anti-TIM 1/HAVCR1 Antibody |
|
PA1632 |
BosterBio |
100ug/vial |
EUR 400.8 |
Anti-TIM 1/HAVCR1 Antibody |
|
RP1093 |
BosterBio |
100ug/vial |
EUR 352.8 |
 AssayMax ELISA Kit) Human Triosephosphate Isomerase (TIM) AssayMax ELISA Kit |
|
ET3025-1 |
AssayPro |
96 Well Plate |
EUR 500.4 |
 TIM-4 Antibody |
|
3813-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma. |
TIM-4 Antibody |
|
3813-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma. |
TIM-4 Antibody |
|
3815-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma. |
TIM-4 Antibody |
|
3815-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma. |
TIM-4 Antibody |
|
24418-100ul |
SAB |
100ul |
EUR 468 |
TIM-4 Antibody |
|
24419-100ul |
SAB |
100ul |
EUR 468 |
 TIM-3 Antibody |
|
8659-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: The immune checkpoint protein TIM-3 is a member of the immunoglobulin superfamily and TIM family of proteins that was initially identified as a specific marker of fully differentiated IFN-γ producing CD4 T helper 1 (Th1) and CD8 cytotoxic cells. It is a Th1-specific cell surface protein that regulates macrophage activation and negatively regulates Th1-mediated auto- and alloimmune responses, and is also highly expressed on regulatory T cells, monocytes, macrophages, and dendritic cells (1). TIM-3 and PD-1 are co-expressed on most CD4 and CD8 T cells infiltrating solid tumors or in hematologic malignancy in mice; blocking TIM-3 in conjugation with a PD-1 blockade increases the functionality of exhausted T cells and synergizes with to inhibit tumor growth (2,3). |
TIM-3 Antibody |
|
8659-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: The immune checkpoint protein TIM-3 is a member of the immunoglobulin superfamily and TIM family of proteins that was initially identified as a specific marker of fully differentiated IFN-γ producing CD4 T helper 1 (Th1) and CD8 cytotoxic cells. It is a Th1-specific cell surface protein that regulates macrophage activation and negatively regulates Th1-mediated auto- and alloimmune responses, and is also highly expressed on regulatory T cells, monocytes, macrophages, and dendritic cells (1). TIM-3 and PD-1 are co-expressed on most CD4 and CD8 T cells infiltrating solid tumors or in hematologic malignancy in mice; blocking TIM-3 in conjugation with a PD-1 blockade increases the functionality of exhausted T cells and synergizes with to inhibit tumor growth (2,3). |
 Tim-1 Recombinant Protein |
|
90-546 |
ProSci |
100 ug |
EUR 752.1 |
|
Description: The TIM (T cell/transmembrane, immunoglobulin and mucin) family plays a critical role in regulating immune responses, including allergy, asthma, transplant tolerance, autoimmunity and the response to viral infections. The unique structure of TIM immunoglobulin variable region domains allows highly specific recognition of phosphatidylserine (PtdSer), exposed on the surface of apoptotic cells. TIM-1 (T cell-immunoglobulinmucin; also KIM-1 and HAVcr-1) is a 100 kDa, type I transmembrane glycoprotein member of the TIM family of immunoglobulin superfamily molecules. There are two cytoplasmic alternate splice forms of TIM1. One is a long (359 aa) kidney form termed TIM-1b, and one is a short (334 aa) liver form termed TIM-1a. TIM-1, important for asthma and allergy, is preferentially expressed on T-helper 2 (Th2) cells and functions as a potent costimulatory molecule for T cell activation. |
Tim-1 Recombinant Protein |
|
90-547 |
ProSci |
100 ug |
EUR 752.1 |
|
Description: The TIM (T cell/transmembrane, immunoglobulin and mucin) family plays a critical role in regulating immune responses, including allergy, asthma, transplant tolerance, autoimmunity and the response to viral infections. The unique structure of TIM immunoglobulin variable region domains allows highly specific recognition of phosphatidylserine (PtdSer), exposed on the surface of apoptotic cells. Tim-1 (KIM-1; HAVcr-1) is a 100 kDa, type I transmembrane glycoprotein member of the TIM family of immunoglobulin superfamily molecules. There are two cytoplasmic alternate splice forms of Tim-1. One is a long (359 aa) kidney form termed Tim-1b, and one is a short (334 aa) liver form termed Tim-1a. Tim-1, important for asthma and allergy, is preferentially expressed on T-helper 2 (Th2) cells and functions as a potent costimulatory molecule for T cell activation. |
 Tim-1, Human Recombinant |
|
P1351-10 |
Biovision |
|
EUR 196.8 |
Tim-1, Human Recombinant |
|
P1351-50 |
Biovision |
|
EUR 627.6 |
 Tim-1, Mouse Recombinant |
|
P1354-10 |
Biovision |
|
EUR 196.8 |
Tim-1, Mouse Recombinant |
|
P1354-50 |
Biovision |
|
EUR 627.6 |
) Anti-TIM 1 (2G11) |
|
YF-MA18139 |
Abfrontier |
100 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to TIM 1 |
) Anti-TIM 1 (1E5) |
|
YF-MA11444 |
Abfrontier |
100 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to TIM 1 |
) Anti-TIM 1 (2B9) |
|
YF-MA11445 |
Abfrontier |
100 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to TIM 1 |
) Polyclonal TIMD4 / TIM4 / TIM-4 Antibody (Internal) |
|
APR02384G |
Leading Biology |
0.05mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIMD4 / TIM4 / TIM-4 (Internal). This antibody is tested and proven to work in the following applications: |
) Polyclonal HAVCR2 / TIM-3 Antibody (aa176-194) |
|
APR03015G |
Leading Biology |
0.05ml |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HAVCR2 / TIM-3 (aa176-194). This antibody is tested and proven to work in the following applications: |
 Histone H3K4 Methylation Antibody Panel Pack |
|
C10005 |
EpiGentek |
|
|
 Histone H3K9 Methylation Antibody Panel Pack |
|
C10006 |
EpiGentek |
|
|
 Histone H3K27 Methylation Antibody Panel Pack |
|
C10007 |
EpiGentek |
|
|
 Histone H3K36 Methylation Antibody Panel Pack |
|
C10008 |
EpiGentek |
|
|
 Histone H3K79 Methylation Antibody Panel Pack |
|
C10009 |
EpiGentek |
|
|
 Histone H4K20 Methylation Antibody Panel Pack |
|
C10012 |
EpiGentek |
|
|
 Histone H4 Acetylation Antibody Panel Pack |
|
C10013 |
EpiGentek |
|
|
 Histone H3 Phosphorylation Antibody Panel Pack |
|
C10014 |
EpiGentek |
|
|
 Histone H3R2 Methylation Antibody Panel Pack |
|
C10015 |
EpiGentek |
|
|
 Histone H3R8 Methylation Antibody Panel Pack |
|
C10016 |
EpiGentek |
|
|
 Histone H3R17 Methylation Antibody Panel Pack |
|
C10017 |
EpiGentek |
|
|
 Histone H3R26 Methylation Antibody Panel Pack |
|
C10018 |
EpiGentek |
|
|
 Histone H4R3 Methylation Antibody Panel Pack |
|
C10019 |
EpiGentek |
|
|
 DNA Methylation Antibody Panel Pack I |
|
C20000 |
EpiGentek |
|
|
 HRP-Goat Anti-Mouse Secondary Antibody |
|
A12003 |
EpiGentek |
|
|
 Antibody) Triosephosphate Isomerase (TIM) Antibody |
|
20-abx141692 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 360.00
|
|
|
|
Triosephosphate Isomerase (TIM) Antibody |
|
20-abx018098 |
Abbexa |
|
|
|
|
Triosephosphate Isomerase (TIM) Antibody |
|
abx018099-100ug |
Abbexa |
100 ug |
EUR 460.8 |
|
|
 Anti-Oncogene TIM antibody |
|
STJ94826 |
St John's Laboratory |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to Oncogene TIM. |
 TIM-3 Antibody / HAVCR2 |
|
V8495-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8495-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8495SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8724-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8724-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8724SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8753-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8753-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8753SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8754-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8754-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8754SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8755-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8755-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8755SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8766-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8766-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8766SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V9177-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cell tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V9177-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cell tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V9177SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cell tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V7533-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The protein encoded by the HAVCR2 gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [RefSeq] |
TIM-3 Antibody / HAVCR2 |
|
V7533-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: The protein encoded by the HAVCR2 gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [RefSeq] |
TIM-3 Antibody / HAVCR2 |
|
V7533IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: The protein encoded by the HAVCR2 gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [RefSeq] |
TIM-3 Antibody / HAVCR2 |
|
V7533SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The protein encoded by the HAVCR2 gene belongs to the immunoglobulin superfamily, and TIM family of proteins. CD4-positive T helper lymphocytes can be divided into types 1 (Th1) and 2 (Th2) on the basis of their cytokine secretion patterns. Th1 cells are involved in cell-mediated immunity to intracellular pathogens and delayed-type hypersensitivity reactions, whereas, Th2 cells are involved in the control of extracellular helminthic infections and the promotion of atopic and allergic diseases. This protein is a Th1-specific cell surface protein that regulates macrophage activation, and inhibits Th1-mediated auto- and alloimmune responses, and promotes immunological tolerance. [RefSeq] |
TIM-3 Antibody / HAVCR2 |
|
V7582-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V7582-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V7582IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V7582SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
 Histone H3 Acetylation Antibody Panel Pack I |
|
C10010 |
EpiGentek |
|
|
 Histone H3 Acetylation Antibody Panel Pack II |
|
C10011 |
EpiGentek |
|
|
 Goat Anti-Rat Secondary Antibody, Biotin Conjugated |
|
A12002 |
EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack I – Active Genes |
|
C10000 |
EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack I – Repression Genes |
|
C10001 |
EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack II – Active Genes |
|
C10002 |
EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack II – Repression Genes |
|
C10003 |
EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack III – Active Genes |
|
C10004 |
EpiGentek |
|
|
 Rabbit Polyclonal Antibody to Human Topoisomerase IIα |
|
TG2011-1 |
TopoGen |
250 units |
EUR 496.8 |
 Polyclonal Rabbit anti-sEH |
|
SEH-1 |
Detroit R&D |
50 uL |
EUR 336 |
) Polyclonal TIMD4 / TIM4 / TIM-4 Antibody (C-Terminus) |
|
APR02278G |
Leading Biology |
0.05mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIMD4 / TIM4 / TIM-4 (C-Terminus). This antibody is tested and proven to work in the following applications: |
 Anti-Sumo 1 Rabbit Monoclonal Antibody |
|
M00631-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal Sumo 1 Antibody. Validated in IP, IF, IHC, WB and tested in Human, Mouse, Rat. |
 Anti-Cytokeratin 1 Rabbit Monoclonal Antibody |
|
M01639-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal Cytokeratin 1 Antibody. Validated in WB and tested in Human, Mouse, Rat. |
 TIM-4 Peptide |
|
3813P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (CT) TIM-4 peptide |
TIM-4 Peptide |
|
3815P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (IN) TIM-4 peptide |
 TIM-3 Peptide |
|
46-495P |
ProSci |
0.1 mg |
EUR 405.6 |
|
Description: TIM3 / HAVCR2 Peptide |
 TIM-50 Peptide |
|
46-496P |
ProSci |
0.1 mg |
EUR 405.6 |
|
Description: TIM50 Peptide |
 Antibody) Human Triosephosphate Isomerase (TIM) Antibody |
|
30187-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 Antibody) T-Cell Immunoglobulin Mucin Receptor 1 (TIM-1) Antibody |
|
abx415204-05mg |
Abbexa |
0.5 mg |
EUR 994.8 |
|
|
T-Cell Immunoglobulin Mucin Receptor 1 (TIM-1) Antibody |
|
abx415206-01mg |
Abbexa |
0.1 mg |
EUR 526.8 |
|
|
T-Cell Immunoglobulin Mucin Receptor 1 (TIM-1) Antibody |
|
abx433377-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
|
T-Cell Immunoglobulin Mucin Receptor 1 (TIM-1) Antibody |
|
abx411874-01mg |
Abbexa |
0.1 mg |
EUR 644.4 |
|
|
 Anti-Integrin beta 1 Rabbit Monoclonal Antibody |
|
M00772-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal Integrin beta 1 Antibody. Validated in IHC, WB and tested in Human, Mouse, Rat. |
 Anti-ARG1/Arginase 1 Rabbit Monoclonal Antibody |
|
M01106-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal ARG1/Arginase 1 Antibody. Validated in IP, WB and tested in Human, Mouse, Rat. |
 Anti-MLANA/Mart 1 Rabbit Monoclonal Antibody |
|
M02033-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal MLANA/Mart 1 Antibody. Validated in IF, WB and tested in Human. |
 Anti-DSG1/Desmoglein 1 Rabbit Monoclonal Antibody |
|
M02655-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal DSG1/Desmoglein 1 Antibody. Validated in IF, IHC, ICC, WB and tested in Human, Mouse, Rat. |
 Anti-HMGB1/Hmg 1 Rabbit Monoclonal Antibody |
|
M00066-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal HMGB1/Hmg 1 Antibody. Validated in Flow Cytometry, IF, IHC, ICC, WB and tested in Human, Mouse, Rat. |
 Anti-p27 KIP 1 Rabbit Monoclonal Antibody |
|
M00173-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Anti-p27 KIP 1 Rabbit Monoclonal Antibody tested for Flow Cytometry, IP, IF, IHC, ICC, WB in Human, Rat |
 Anti-MHC class 1 Rabbit Monoclonal Antibody |
|
M00194-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal MHC class 1 Antibody. Validated in IP, IF, IHC, WB and tested in Human. |
 Anti-BOB-1/OBF-1 Rabbit Monoclonal Antibody, Clone#RM378 |
|
M04431-1 |
BosterBio |
100uL |
EUR 462 |
|
Description: Anti-BOB-1/OBF-1 Rabbit Monoclonal Antibody, Clone#RM378 tested in WB, IHC, reactive to Human |
 Anti-AFP/Alpha 1 Fetoprotein Rabbit Monoclonal Antibody |
|
M00522-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal AFP/Alpha 1 Fetoprotein Antibody. Validated in IP, IF, WB and tested in Human. |
 Anti-SERPINA1/Alpha 1 Antitrypsin Rabbit Monoclonal Antibody |
|
M00720-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal SERPINA1/Alpha 1 Antitrypsin Antibody. Validated in IP, IF, WB and tested in Human. |
 Anti-GPX1/Glutathione Peroxidase 1 Rabbit Monoclonal Antibody |
|
M01019-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal GPX1/Glutathione Peroxidase 1 Antibody. Validated in IP, WB and tested in Human, Mouse, Rat. |
 Anti-BAG-1 Rabbit Monoclonal Antibody, Clone#RM356 |
|
M02423-1 |
BosterBio |
100uL |
EUR 462 |
|
Description: Anti-BAG-1 Rabbit Monoclonal Antibody, Clone#RM356 tested in WB, IHC, reactive to Human |
 Magnetic Separator) EpiMag HT (96-Well) Magnetic Separator |
|
Q10002 |
EpiGentek |
|
|
 ) EpiMag 96-Well Microplate (5/pack) |
|
Q10003 |
EpiGentek |
|
|
 Antibody (FITC)) T-Cell Immunoglobulin Mucin Receptor 1 (TIM-1) Antibody (FITC) |
|
abx415205-01mg |
Abbexa |
0.1 mg |
EUR 610.8 |
|
|
 Antibody (RPE)) T-Cell Immunoglobulin Mucin Receptor 1 (TIM-1) Antibody (RPE) |
|
abx415207-100tests |
Abbexa |
100 tests |
EUR 710.4 |
|
|
 Rabbit Monoclonal Antibody) Anti-Phospho-AMPK alpha 1 (S496) Rabbit Monoclonal Antibody |
|
P00994-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal Phospho-AMPK alpha 1 (S496) Antibody. Validated in IP, IF, WB and tested in Human. |
TIM-1 Rabbit Polyclonal Antibody
